The evolutionary analysis of emerging low frequency HIV-1 CXCR4 using variants through time--an ultra-deep approach.

by John Archer, Andrew Rambaut, Bruce E Taillon, P Richard Harrigan, Marilyn Lewis, David L Robertson
Published 2010-12-01

Quality Control of Next-Generation Sequencing-Based HIV-1 Drug Resistance Data in Clinical Laboratory Information Systems Framework

by Rupert Capina, Katherine Li, Levon Kearney, Anne-Mieke Vandamme, P. Richard Harrigan, Kristel Van Laethem
Published 2020-06-01

HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic study

by Marianne Harris, Bruce Ganase, Birgit Watson, P. Richard Harrigan, Julio S. G. Montaner, Mark W. Hull
Published 2017-11-01

Estimation of measurement error in plasma HIV-1 RNA assays near their limit of quantification.

by Viviane D Lima, Lu Wang, Chanson Brumme, Lang Wu, Julio S G Montaner, P Richard Harrigan
Published 2017-01-01

Compounds producing an effective combinatorial regimen for disruption of HIV‐1 latency

by Pargol Hashemi, Kris Barreto, Wendy Bernhard, Adam Lomness, Nicolette Honson, Tom A Pfeifer, P Richard Harrigan, Ivan Sadowski
Published 2018-02-01

"Dynamic range" of inferred phenotypic HIV drug resistance values in clinical practice.

by Luke C Swenson, Graham Pollock, Brian Wynhoven, Theresa Mo, Winnie Dong, Robert S Hogg, Julio S G Montaner, P Richard Harrigan
Published 2011-02-01

Structural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usage.

by Oliver Sander, Tobias Sing, Ingolf Sommer, Andrew J Low, Peter K Cheung, P Richard Harrigan, Thomas Lengauer, Francisco S Domingues
Published 2007-03-01

Mapping the shapes of phylogenetic trees from human and zoonotic RNA viruses.

by Art F Y Poon, Lorne W Walker, Heather Murray, Rosemary M McCloskey, P Richard Harrigan, Richard H Liang
Published 2013-01-01

Development and validation of a composite programmatic assessment tool for HIV therapy.

by Viviane D Lima, Adrian Le, Bohdan Nosyk, Rolando Barrios, Benita Yip, Robert S Hogg, P Richard Harrigan, Julio S G Montaner
Published 2012-01-01

Measuring enzymatic HIV-1 susceptibility to two reverse transcriptase inhibitors as a rapid and simple approach to HIV-1 drug-resistance testing.

by Dieter Hoffmann, Albert D Garcia, P Richard Harrigan, Ian C D Johnston, Tadashi Nakasone, J Gerardo García-Lerma, Walid Heneine
Published 2011-01-01

Sociodemographic correlates of HIV drug resistance and access to drug resistance testing in British Columbia, Canada.

by Genevieve Rocheleau, Conrado Franco-Villalobos, Natalia Oliveira, Zabrina L Brumme, Melanie Rusch, Jeannie Shoveller, Chanson J Brumme, P Richard Harrigan
Published 2017-01-01

Technical and regulatory shortcomings of the TaqMan version 1 HIV viral load assay.

by Chanson J Brumme, Luke C Swenson, Brian Wynhoven, Benita Yip, Stuart Skinner, Viviane Dias Lima, Julio S G Montaner, P Richard Harrigan
Published 2012-01-01

Prolonged and substantial discordance in prevalence of raltegravir-resistant HIV-1 in plasma versus PBMC samples revealed by 454 "deep" sequencing.

by Guinevere Q Lee, Luke C Swenson, Art F Y Poon, Jeffrey N Martin, Hiroyu Hatano, Steven G Deeks, P Richard Harrigan
Published 2012-01-01

Reconstructing the dynamics of HIV evolution within hosts from serial deep sequence data.

by Art F Y Poon, Luke C Swenson, Evelien M Bunnik, Diana Edo-Matas, Hanneke Schuitemaker, Angélique B van 't Wout, P Richard Harrigan
Published 2012-01-01

Are We Ready for NGS HIV Drug Resistance Testing? The Second “Winnipeg Consensus” Symposium

by Hezhao Ji, Paul Sandstrom, Roger Paredes, P. Richard Harrigan, Chanson J. Brumme, Santiago Avila Rios, Marc Noguera-Julian, Neil Parkin, Rami Kantor
Published 2020-05-01

HIV-1 Genetic Diversity in Antenatal Cohort, Canada

by Bertine S. Akouamba, Janique Viel, Hugues Charest, Natacha Merindol, Johanne Samson, Normand Lapointe, Bluma G. Brenner, Richard Lalonde, P. Richard Harrigan, Marc Boucher, Hugo Soudeyns
Published 2005-08-01

Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs

by Vincent Montoya, Anita Y. M. Howe, Weiyan Y. Dong, Winnie Dong, Chanson J. Brumme, Andrea D. Olmstead, Kanna Hayashi, P. Richard Harrigan, Jeffrey B. Joy
Published 2021-05-01

An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing.

by Raymond W Wong, Ahalya Balachandran, Peter K Cheung, Ran Cheng, Qun Pan, Peter Stoilov, P Richard Harrigan, Benjamin J Blencowe, Donald R Branch, Alan Cochrane
Published 2020-02-01

"Deep" sequencing accuracy and reproducibility using Roche/454 technology for inferring co-receptor usage in HIV-1.

by David J H F Knapp, Rachel A McGovern, Art F Y Poon, Xiaoyin Zhong, Dennison Chan, Luke C Swenson, Winnie Dong, P Richard Harrigan
Published 2014-01-01

Limited evolution of inferred HIV-1 tropism while viremia is undetectable during standard HAART therapy.

by Guinevere Q Lee, Winnie Dong, Theresa Mo, David J H F Knapp, Chanson J Brumme, Conan K Woods, Steve Kanters, Benita Yip, P Richard Harrigan
Published 2014-01-01